Although HIF‐1α‐triggered VEGF activation is a principal mechanism leading to angiogenesis in HCC, the inhibition of VEGF production in geniposide‐treated HCC was not accompanied by changes in HIF‐1α. The gene discussed is VEGFA; the disease is hepatocellular carcinoma.